IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 17 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $191,000 | +26.5% | 68,853 | 0.0% | 0.00% | – |
| Q2 2018 | $151,000 | +24.8% | 68,853 | 0.0% | 0.00% | – |
| Q1 2018 | $121,000 | +3.4% | 68,853 | 0.0% | 0.00% | – |
| Q4 2017 | $117,000 | +6.4% | 68,853 | 0.0% | 0.00% | – |
| Q3 2017 | $110,000 | -50.0% | 68,853 | 0.0% | 0.00% | – |
| Q2 2017 | $220,000 | +33.3% | 68,853 | +73.1% | 0.00% | – |
| Q1 2017 | $165,000 | +275.0% | 39,779 | +123.4% | 0.00% | – |
| Q4 2016 | $44,000 | -34.3% | 17,805 | +1.1% | 0.00% | – |
| Q3 2016 | $67,000 | +1.5% | 17,617 | +0.3% | 0.00% | – |
| Q2 2016 | $66,000 | -4.3% | 17,570 | 0.0% | 0.00% | – |
| Q1 2016 | $69,000 | -43.4% | 17,570 | -0.3% | 0.00% | – |
| Q4 2015 | $122,000 | +60.5% | 17,617 | +48.4% | 0.00% | – |
| Q3 2015 | $76,000 | – | 11,869 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,205,000 | $8,351,000 | 3.49% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 622,744 | $4,316,000 | 1.61% |
| MARATHON CAPITAL MANAGEMENT | 25,000 | $173,000 | 0.09% |
| Granite Investment Partners, LLC | 125,251 | $868,000 | 0.08% |
| REGIONS FINANCIAL CORP | 30,500 | $211,000 | 0.00% |
| CIBC Private Wealth Group, LLC | 29,297 | $203,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 576 | $4,000 | 0.00% |
| Formidable Asset Management, LLC | 300 | $2,000 | 0.00% |
| BlackRock Investment Management, LLC | 1,211 | $8,000 | 0.00% |
| CITIGROUP INC | 25 | $0 | 0.00% |